A case of bullous pemphigoid after a long‐term administration of anti‐PD‐1 antibodies in a patient with non‐small‐cell lung cancer
We described a case of BP that developed 2.5 years after the administration of nivolumab for metastatic non‐small cell lung cancer. Our report highlights the fact that dermatologists should be aware of anti PD‐1‐related BP, which can appear very late during treatment.
Guardado en:
Autores principales: | Emi Yokoyama, Osamu Yamasaki, Toshio Kubo, Hiroshi Koga, Norito Ishii, Shin Morizane |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c13686787fc34df6b290fef44c1c5e16 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bullous pemphigoid induced by Hijama therapy (cupping)
por: Arghavan Azizpour, et al.
Publicado: (2018) -
Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment
por: Vito Di Lernia, et al.
Publicado: (2020) -
Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
por: Maryam Aghighi, et al.
Publicado: (2020) -
Solitary Bullous Mastocytoma with Dermoscopic Features in a Neonate
por: Özge Gündüz, et al.
Publicado: (2019) -
The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19)
por: Andrey A. Martynov, et al.
Publicado: (2021)